CoLucid Pharmaceuticals Announces Initiation of Second Phase 3 Pivotal Trial of Lasmiditan in Migraine
19 mai 2016 12h46 HE
|
CoLucid Pharmaceuticals, Inc
First Patient Randomized in SPARTAN StudyTrial Being Conducted Under Special Protocol Assessment Agreement with FDA CAMBRIDGE, Mass., May 19, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals,...
2008 LA FIT EXPO to Showcase InFITnity
15 févr. 2008 16h11 HE
|
InFITnity
LOS ANGELES, CA--(Marketwire - February 15, 2008) - Luthier PR -- Typically when you think of a
fitness expo or anything assimilated to this type of event, images of
bodybuilders, vitamins and health...